Health Canada Approves Hologic's Aptima HPV Assay for Panther Platform | GenomeWeb

NEW YORK (GenomeWeb News) – Health Canada has approved Hologic's Aptima HPV assay for use on the Panther system, the company said on Thursday.

The test is performed with Hologic's ThinPrep liquid cytology specimen and can be used before or after it has been processed for cytology testing on the ThinPrep 2000 system. The mRNA-based assay is a nucleic acid amplified test for detecting 14 high-risk strains of human papillomavirus associated with cervical cancer and precancerous lesions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.